Skip Ribbon Commands
Skip to main content

Terumo Europe in Heverlee (Belgium) recognised again as ‘Factory of the Future’

​Terumo Europe’s production site has once again been recognised as a Factory of the Future (2026–2028), a title awarded by Agoria and Sirris. Following the previous award for 2022–2025, this renewed recognition confirms the site’s continued evolution. At the Heverlee location, Terumo primarily manufactures injection needles and injection solutions for healthcare professionals and patients worldwide. This recognition aligns with Terumo’s mission of contributing to society through healthcare.​​

2/11/2026 - Heverlee, Belgium

The Factory of the Future award honours companies that organise their production with a future‑focused approach, with attention to innovation, sustainability, digitalisation, technology, efficient processes, and employee development.

For Terumo’s site in Heverlee, the renewal is confirmation of their commitment to continuous improvement. COO Henk Houf: “Receiving the Factory of the Future label again is, first and foremost, an appreciation for all our colleagues in Heverlee. Their expertise, dedication, and care for quality make the difference for patients who rely on our solutions. This recognition encourages us to keep improving with the same commitment.”

With its state‑of‑the‑art production environment and strong investment in employee craftsmanship, the site continues to strengthen its role as a reliable partner for the pharmaceutical industry, hospitals, and healthcare professionals.

The renewed recognition for 2026–2028 shows that the site remains committed to progress and to delivering high‑quality solutions that benefit patient care.

***

About Terumo Europe

Terumo Europe N.V. is a core player in the EMEA healthcare market by providing best-in-class quality medical products and services. We are a strong actor of the Terumo Group by contributing to innovation and sustainable growth. Terumo Europe produces, distributes, markets, and sells a vast range of medical devices in five main business units: Interventional Systems, Pharmaceutical Solutions, Hospital Care Solutions, Cardiovascular and Life Care Solutions. Terumo Europe EMEA headquarters and production facilities are located in Leuven (Belgium), European Distribution Center in Genk (Belgium) and sales offices across EMEA.

Please visit www.terumo-europe.com for more information.


Media contact

Geert Lambrechts
Director Corporate Communications | Terumo EMEA
Geert.lambrechts@Terumo-europe.com
Mobile: +32 (0)473/637 892


Images below can be downloaded here​ in high resolution.

Terumo_EMEA Headquarters2.jpgTerumo_EMEA Headquarters3.jpgTerumo EMEA Headquarter.jpg